TKIs, Apoptotic Enhancers, and other Small Molecules in the Pipeline

TKIs, Apoptotic Enhancers, and other Small Molecules in the Pipeline

HMP CME

4 years
514 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In this presentation from "Lymphoma and Myeloma 2015: An International Congress on Hematologic Malignancies", Dr. Steve Coutre discusses tyrosine-kinase inhibitors (TKIs), apoptotic enhancers, and other small molecules in the pipeline for the treatment of chronic lymphocytic leukemia (CLL).

A continuing education program is offered as a supplement to this webcast at the following location:
http://elc.imedex.com/ELC/Activity-Search.aspx?search=LM2015EP

© 2015 Imedex, LLC.
Up Next Autoplay